Zydus Lifesciences Acquires 85.6% Stake in Amplitude Surgical
March 11, 2025
Zydus Lifesciences agreed to acquire an 85.6% controlling stake in French medtech company Amplitude Surgical for €6.25 per share (total consideration €256.8 million) and has completed the block acquisition. Zydus will file a mandatory simplified cash tender offer for the remaining shares at the same price with the aim of securing >90% of capital and implementing a squeeze-out and delisting; Amplitude Surgical is a Valence-based leader in lower-limb orthopaedic implants with ~429 employees and ~€111m revenue (FY Jun 2025).
- Buyers
- Zydus Lifesciences Limited
- Targets
- Amplitude Surgical
- Sellers
- PAI Partners, Amplitude Surgical management (including founder/CEO Olivier Jallabert), Two minority shareholders
- Industry
- Medical Devices
- Location
- Auvergne-Rhône-Alpes, France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
PAI Partners Agrees to Acquire Majority Stake in Amplitude Surgical
July 30, 2020
Medical Devices
PAI Partners has entered into exclusive negotiations to acquire a majority stake in Amplitude Surgical from Apax Partners and certain managers via an SPV, at a price of €2.15 per share, with a subsequent mandatory public tender offer planned. The transaction preserves existing management involvement and is intended to support Amplitude Surgical's continued international expansion and product development in lower-limb orthopedics.
-
Surgical Notes Acquires Zulu Health
August 6, 2021
Healthcare Services
Surgical Notes has acquired Zulu Health, a Los Angeles-based revenue cycle management (RCM) provider focused on ambulatory surgery centers (ASCs). The deal brings Zulu Health's leadership and RCM capabilities into Surgical Notes (a CapStreet Group portfolio company) to expand and strengthen ASC-focused RCM services nationwide.
-
Zimmer Biomet Acquires A&E Medical Corporation
December 1, 2020
Medical Devices
Zimmer Biomet completed the acquisition of A&E Medical Corporation from private equity owner Vance Street Capital for $250 million. A&E Medical, headquartered in Farmingdale, New Jersey, is a designer and manufacturer of sternal closure systems, cardiac pacing wires and related disposable surgical products; the deal expands Zimmer Biomet's capabilities and product portfolio in cardiovascular and cardiothoracic surgical devices.
-
Investor Consortium Acquires Majority Stake in HistoSonics at $2.25B Valuation
August 10, 2025
Medical Devices
HistoSonics, a University of Michigan spin-out developer of the Edison Histotripsy System, sold a majority stake to a consortium led by K5 Global, Bezos Expeditions and Wellington Management in a transaction valuing the company at $2.25 billion. Other investors included Alpha JWC Ventures, Alpha Wave Ventures and Johnson & Johnson’s JJDC; proceeds will be used to accelerate clinical programs and expand the company’s indications and commercial rollout (CEO Mike Blue will become chairman).
-
Quantum Surgical Acquires NeuWave Medical
February 27, 2026
Medical Devices
Quantum Surgical has acquired NeuWave Medical and combined both businesses under a newly created parent, Precision IO Group Inc., to expand a robotic-assisted tumor ablation platform. The deal is supported by investment from Ally Bridge Group and aims to integrate Quantum Surgical's Epione robotic system with NeuWave's microwave ablation technology to broaden access to minimally invasive interventional oncology care.
-
Zydus Lifesciences Acquires Agenus' U.S. Biologics Manufacturing Facilities and Launches Zylidac Bio LLC
January 16, 2026
Biotechnology
Zydus Lifesciences Limited has completed purchase agreements with Agenus Inc. to acquire Agenus' biologics manufacturing facilities and operations in Emeryville and Berkeley, California, and has established a U.S. CDMO subsidiary, Zylidac Bio LLC, to operate the assets. The deal includes exclusive manufacturing arrangements for Agenus' Phase 3 immuno-oncology candidates (botensilimab and balstilimab), exclusive commercialization rights for those assets in India and Sri Lanka, and an equity investment in Agenus via Zynext Ventures; regulatory approvals including CFIUS clearance were secured.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.